Analysis of the Beat-AML cohort further confirmed the robust prognostic predictive power of BATF (AUC3year = 0.85) (Figure 3E), where high BATF expression was linked to worse OS (3-year OS: 35.71% vs. 63.16%, P = 0.017) (Figure 3E). Here, BATF is linked to acute myeloid leukemia.